Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2000
08/02/2000CN1261915A A process for preparing an anti-oxidant
08/02/2000CN1261914A Alkaline xyloglucanase
08/02/2000CN1261896A Surface antigens and proteins useful in compositions for diagnosis and prevention of lyme disease
08/02/2000CN1261893A 3'-monophosphorylating oligonucleotides
08/02/2000CN1261808A Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
08/02/2000CN1261626A Method for producing L-amino acid
08/02/2000CN1055123C Protein structure of plant torin gelonin
08/02/2000CN1055122C Structural method of anti-body albumen A-DNA probe
08/02/2000CN1055121C Genetic transformation and generation method for capsicum plant
08/02/2000CA2297507A1 Synthetic gene of bovine viral diarrhoea virus
08/02/2000CA2295920A1 Oligonucleotide reverse transcription primers for efficient detection of hiv-1 and hiv-2 and methods of use thereof
08/01/2000US6096950 Cotton fiber-specific promoters
08/01/2000US6096947 Methods for improving transformation efficiency
08/01/2000US6096946 Control of pod dehiscence
08/01/2000US6096945 Modification of starch content in plants
08/01/2000US6096880 Circular DNA vectors for synthesis of RNA and DNA
08/01/2000US6096878 Polynucleotide coding heavy chain peptides of antibodies; for amplification of diversity in animals
08/01/2000US6096877 Cdna sequences coding a protein with inhibitory activity
08/01/2000US6096876 1-α-hydroxylase materials and methods
08/01/2000US6096875 Nucleoside/nucleotide including base, rigid linker, spacer and member of linkage pair or label; for terminators and chain-extenders in sanger-type dna sequencing or polymerase chain reactions
08/01/2000US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents
08/01/2000US6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
08/01/2000US6096869 Treatment of papillomavirus-associated lesions
08/01/2000US6096868 ECR 673: A 7-transmembrane G-protein coupled receptor
08/01/2000US6096867 Ice candy composed of one or more antifreeze proteins isolated from plants; for the reduction in ice crystal size
08/01/2000US6096866 Netrins
08/01/2000US6096862 Multimeric antiviral agent
08/01/2000US6096722 Non-steroidal treatment/prophylaxis
08/01/2000US6096720 Liposomal oligonucleotide compositions
08/01/2000US6096718 Tissue specific adenovirus vectors for breast cancer treatment
08/01/2000US6096717 Inserting a tag-creating dna into an intron within a gene whereby the dna has a structure that creates two hybrid introns separated by a new exon encoding the protein tag
08/01/2000US6096716 Directly injecting to injured tissue of brain or spinal cord a nucleic acid segment encoding a neurotrophin and a liposome comprising cationic lipid(s)
08/01/2000US6096715 Chimeric ribosyme having first and second oligodeoxyribonucleotide sequences which are complementary to the sequences adjacent to the cleavage site of an rna substrate
08/01/2000US6096708 Insecticides
08/01/2000US6096706 Growth-promoting proteins and peptides for kidney epithelial cells
08/01/2000US6096551 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
08/01/2000US6096549 Method of selection of allelic exchange mutants
08/01/2000US6096548 Increasing efficiency of viral infection of a host cell by recombination of viral dna segments to produce a library, contacting host cells, and screening for viruses that infect the host cells, repeating until desired efficiency
08/01/2000US6096547 Growing dicotyledon cells containing an expression cassette including regulatory sequences and the structural gene coding for polypeptide of interest; produces physiologically active proteins
08/01/2000US6096546 Efficient process by using transformed plant which expresses and secretes heterologous polypeptide; externally contacting plant or intact portion with aqueous medium forming mixture of medium and exudate, and recovering polypeptide
08/01/2000US6096545 Dna encoding a protein kinase of a plant; for transgenic plants with modified phosphorus metabolism
08/01/2000US6096543 Antisense inhibition of human mek1 expression
08/01/2000US6096541 Hepatocyte cell culture which replicates hepatitis c virus; for screening viricides
08/01/2000US6096539 Protein activator of apoptosis
08/01/2000US6096538 Retroviral vectors
08/01/2000US6096535 Feline infectious peritonitis vaccine
08/01/2000US6096534 Nucleic acid of long terminal repeat from virus, of gag and pol regions of virus, and from viral envelope region; vectors which replicate efficiently in avian cells and replication-defective in mammalian cells; gene therapy and vaccines
08/01/2000US6096529 Recombinant α-2,3-sialyltransferases and their uses
08/01/2000US6096527 Nucleic acids encoding protein tryosine kinases
08/01/2000US6096526 Amino acid sequences; for diagnosis, treatment and prevention of cancer and developmental disorders; anticarcinogenic agents; antagonists; agonists; antibodies; hybridization probes; recombinant production of enzyme
08/01/2000US6096523 Transformation vector system
08/01/2000US6096521 Adhesin from Helicobacter pylori
08/01/2000US6096520 Brain glycogen phosphorylase cancer antigen
08/01/2000US6096519 Chlamydia trachomatis serotype D proteins
08/01/2000US6096518 DNA encoding SPO/REL polypeptides of streptococcus
08/01/2000US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides
08/01/2000US6096516 cDNAs encoding murine antibody against human plasma apolipoprotein B-100
08/01/2000US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related
08/01/2000US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics
08/01/2000US6096512 Cloned DNA encoding a UDP-GalNAc: Polypeptide, N-acetylgalactosaminyltransferase
08/01/2000US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor
08/01/2000US6096506 Antibodies specific for growth differentiation factor-8 and methods of using same
08/01/2000US6096505 Cotransfecting mammalian cells with separate nucleic acid elements including one with promoter, one with marker, and one with gene; culturing for gene expression; selecting cells which express the marker; then cells that express polypeptide
08/01/2000US6096504 Maize glutathione-S-transferase enzymes
08/01/2000US6096503 Differential display which reduces uncertain aspect of 5' end generation and allows reproduciblity in different settings; does not depend on mismatched priming
08/01/2000US6096501 Nucleotide sequences of oligonucleotides used as primers and probes for rapid diagnosis of infection
08/01/2000US6096335 Stable particulate complexes having a lamellar, rolled, and condensed structure
08/01/2000US6096323 Vaccine against papillomatous digital dermatitis (PDD)
08/01/2000US6096320 Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica
08/01/2000US6096319 Peptides with amino acid sequences
08/01/2000US6096308 Human protein kinase and kinase inhibitors
08/01/2000US6096306 Strains of Bacillus thuringiensis and pesticide composition containing them
08/01/2000US6096305 Receptor that binds IL-17
08/01/2000US6096304 Neurotoxins coding nucleotide sequences for gene expression
08/01/2000US6096300 Suppression of myeloproliferation and anticarcinogenic agents
08/01/2000US6096020 Electroporation employing user-configured pulsing scheme
08/01/2000CA2201601C Chimeric papillomavirus-like particles
08/01/2000CA2199832C Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
08/01/2000CA2185436C Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases
08/01/2000CA2184004C Production of fibrinogen in transgenic animals
08/01/2000CA2175061C Muteins of beta-galactosidase fragments having increased activity
08/01/2000CA2175060C Oxidation-resistant muteins of beta-galactosidase fragments
08/01/2000CA2134240C Novel peptide having elastase inhibitor activity and process for producing the same
08/01/2000CA2127091C Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines
08/01/2000CA2102264C Boron silicates, aluminum silicates, phosphosilicates and purification of dna
08/01/2000CA2099976C Repressors of the trans-activating function of papillomavirus e2 proteins
08/01/2000CA2047717C Monoclonal antibodies for small moieties, methods therefor
08/01/2000CA2025350C Process for production of c-terminal .alpha.-amidated peptide
08/01/2000CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
08/01/2000CA1341070C Pulmonary surfactant protein and related polypeptide
08/01/2000CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease
07/2000
07/29/2000CA2297137A1 New gene with down-regulated expression in metastatic human melanoma cells and a protein coded thereby, methods of production, and use thereof
07/29/2000CA2258972A1 Apoptosis inhibitory protein, gene encoding the protein and cdna thereof
07/27/2000WO2000043939A1 Describing and storing method of alignment information
07/27/2000WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor
07/27/2000WO2000043781A2 Growth differentiation factor inhibitors and uses therefor
07/27/2000WO2000043754A1 Raman optrode processes and devices for detection of chemicals and microorganisms
07/27/2000WO2000043544A1 Method for controlling the extension of an oligonucleotide
07/27/2000WO2000043541A1 Selection procedure using prodrug/enzyme system
07/27/2000WO2000043540A1 A method of dna sequencing